- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,050.00
7D
-3.2%
1Y
-1.8%
HansBiomed
Market Cap: ₩265.3b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩18,600.00
7D
-5.6%
1Y
137.5%
ALTEOGEN
Market Cap: ₩16.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩308,500.00
7D
2.7%
1Y
-26.9%
DreamCIS
Market Cap: ₩69.6b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩2,830.00
7D
-1.4%
1Y
-9.3%